For nearly three decades, leading life sciences industry stakeholders have chosen ACI and C5’s Global Series of Life Sciences events as their leading source for business and legal information. Top executives, attorneys, and policy makers for the many industries that comprise the life sciences industry — including the pharmaceutical, biotechnology, and medical device/diagnostics industries– have turned to our events as a trusted resource
Our life sciences events cover every facet of legal and business relevance as well as controversy. We produce industry -leading events on life sciences regulation, policy, compliance, liability, and IP. Words and phrases – which we coined –such as “Drug and Med”, “Paragraph IV”, and “FDA Boot Camp” among others are now part of common industry parlance… and this vocabulary continues to grow with events that cover new and novel modalities and therapies such as mRNA and CRSPR, as well as AI.
We are also honored to work with distinguished industry leaders who form our advisory boards, leading policy makers, including executives for PhRMA, BIO, and AAM, as well as members of the judiciary, and representatives from key agencies such as FDA, FTC, and PTO.
We provide the most innovative training, networking, and relevant content necessary to develop evolving playbooks in these disciplines that will allow you to thrive in the coming years.